SynthesisSpine deformity2026
Scoliosis surgery outcomes in the setting of osteogenesis imperfecta: a scoping systematic review and meta-analysis.
Synthesis in Spine deformity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delayed, deep Corynebacterium surgical site infection following scoliosis corrective surgery in a patient with osteogenesis imperfecta: a case report.Journal of medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteogenesis imperfecta (OI) is a rare genetic condition that leads to poor bone quality and scoliosis development. To date, the surgical management of scoliosis in the setting of OI is poorly defined, be it with traditional posterior spinal fusion (PSF) or newer growth-friendly instrumentation (GFI) approaches. Correspondingly, the aim of this study was to quantitatively pool the available metadata in the literature regarding the surgical outcomes of OI patients undergoing surgical correction.
methodsMultiple electronic databases from inception to August 2025 were searched following PRISMA guidelines. Respective cohort-level outcomes were then abstracted and pooled by means of meta-analysis utilizing random-effects modeling, and trends were evaluated by meta-regression analysis.
resultsA total of 14 studies were identified for inclusion, describing 321 OI patients surgically treated by PSF (n = 301, 94%) and GFI (n = 20, 6%). Across the cohort, median male percentage and mean age at surgery were 46% and 14.1 years, respectively; 20% were OI type 1, 51% were OI type 3, and 9% were OI type 4 as reported by Sillence Classification. Adjuncts described included traction in 8/14 (57%) studies, preoperative bisphosphonates in 6/14 (43%) studies, and intraoperative cement in 3/14 (21%) studies. Meta-analysis demonstrated overall incidence of postoperative complications following surgical correction of scoliosis to be 21% (95% CI 12-31%), with a statistical difference between PSF and GFI groups (P-heterogeneity < 0.01). Trim-and-fill analyses imputed 3 additional studies to re-estimate the complication incidence to be lower at 14% (95% CI 3-24%) for the PSF-only group. Pooled incidence of revision surgery was 6% (95% CI 2-12%), with a statistical difference between PSF and GFI groups (P-heterogeneity < 0.01) as well. Certainty of outcomes was deemed very low, with quality of evidence ranging from high to moderate.
conclusionOverall, there are non-negligible complication and revision rates in the surgical treatment of scoliosis in the setting of OI. These rates are lower in the setting of PSF alone, and the use of surgical adjuncts and GFI approaches requires further study to understand their role in the treatment paradigm of OI scoliosis. Larger, collaborative efforts will improve the granularity of our findings in the future.
Indexed as
Identifiers
41526788What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.